| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Revenue | $1.30B | +27.4% |
| Cost of Revenue | $896.3M | +27.2% |
| Gross Profit | $399.9M | +27.7% |
| R&D Expense | $23.7M | -18.7% |
| SG&A Expense | $289.5M | +11.4% |
| Operating Income | $110.5M | +107.2% |
| Pre-tax Income | $68.0M | +522.9% |
| Income Tax | $19.7M | +132.1% |
| Net Income | $48.3M |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.0M | -3.6% |
| Short-term Investments | $9.0M | -79.5% |
| Accounts Receivable | $228.0M | +34.5% |
| Inventory | $444.4M | +67.1% |
| Current Assets | $810.6M | +34.9% |
| Total Assets | $1.36B | +38.6% |
| Current Liabilities | $293.5M | +43.8% |
| Line Item | 2025-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $80.1M | -8.5% |
| Investing Cash Flow | -$288.7M | -499.0% |
| Financing Cash Flow | $207.1M | +3160.5% |
| +1897.7% |
| EPS (Basic) | $1.19 | +1883.3% |
| EPS (Diluted) | $1.19 | +1883.3% |
| Total Liabilities |
| $1.08B |
| +48.2% |
| Stockholders' Equity | $285.7M | +11.3% |